Of the $98 million in country grants approved by Global Fund Board from 2017-2019 allocations, Latin America and Caribbean receive $57 million
This is the second of two articles in this issue on the grants recently approved by the Global Fund Board. In this article, we report on the comments of the Grant Approvals Committee (GAC) on four countries in the Latin American and Caribbean region: Belize, El Salvador, Panama and Paraguay.
On 12 November 2018, through electronic voting, the Global Fund Board approved $98.0 million in funding for 14 country grants from 13 countries. Of the 14 grants, four were for TB; three TB/HIV; three HIV; three malaria; and one TB/RSSH.
Global Fund grant will expand HIV prevention, care and treatment services for key populations in Guyana
Among the batch of grants recently approved by the Board was an HIV grant to Guyana. The proposed timeframe for the grant was 1 January 2018 to 31 December 2020. The principal recipient (PR) is the Ministry of Health, which also managed Guyana’s previous HIV grant.
Tool developed by Global Fund and APMG Health used in transitioning countries to assess sustainability of services for key populations
As more and more countries in Latin America and the Caribbean (LAC) become ineligible for funding from the Global Fund, there have been legitimate concerns about the sustainability of the response to the diseases in these countries – in particular, whether civil society organizations (CSOs) will be able to continue to play the vital role of providing prevention, treatment and care services for key and vulnerable populations.
Between 29 March and 13 April 2016, the Office of the Inspector General published reports on three investigations – one each in India, Guyana and Bangladesh. The OIG identified non-compliant expenditures ranging from $56,966 for a malaria grant in Guyana to $311,637 for a TB grant in Bangladesh. This article provides a brief summary of the OIG’s findings.